rxstat › Shortages › Repaglinide
Repaglinide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Repaglinide products are in shortage in Canada (6 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
In shortage since
Nov 1, 2021
Est. full return
Sep 4, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageJAMP REPAGLINIDE
2MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354942 · since Oct 31, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortageJAMP REPAGLINIDE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354934 · since Oct 31, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortageJAMP REPAGLINIDE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354926 · since Oct 31, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortageACT REPAGLINIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02321491 · since Nov 16, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortageACT REPAGLINIDE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02321483 · since Nov 1, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortageACT REPAGLINIDE
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02321475 · since Nov 1, 2021, no end estimate · Disruption of the manufacture of the drug.
ResolvedJAMP REPAGLINIDE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354934 · ended Sep 19, 2025 · Disruption of the manufacture of the drug.
ResolvedJAMP REPAGLINIDE
2MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354942 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
ResolvedJAMP REPAGLINIDE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354926 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
ResolvedAURO-REPAGLINIDE
1MG · TABLET · AURO PHARMA INC
DIN 02424266 · ended Nov 15, 2024 · Demand increase for the drug.
ResolvedREPAGLINIDE
2MG · TABLET · PRO DOC LIMITEE
DIN 02415984 · ended Oct 18, 2024 · Delay in shipping of the drug.
ResolvedREPAGLINIDE
0.5MG · TABLET · PRO DOC LIMITEE
DIN 02415968 · ended Oct 18, 2024 · Delay in shipping of the drug.
Showing 12 of 54 reports. All reports are on file with Health Canada.
What's happening
Repaglinide is currently affected by 6 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Repaglinide is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BX).
Recent changes
Common questions
When will Repaglinide be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Repaglinide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.